Page 75 - Read Online

67. Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, 71. Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E,
Montgomery E, Deasel M, Germonpre P, Rubinson L, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.
Heitmiller RF, Yang SC, Forastiere AA, Baylin SB, Herman JG. EP300-a miRNA-regulated metastasis suppressor gene
Prognostic importance of promoter hypermethylation of in ductal adenocarcinomas of the pancreas. Int J Cancer
multiple genes in esophageal adenocarcinoma. Clin Cancer 2010;126:114-24.
Res 2003;9:2912-9. 72. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S,
68. Sarbia M, Geddert H, Klump B, Kiel S, Iskender E, Miyazono K. Modulation of microRNA processing by p53.
Gabbert HE. Hypermethylation of tumor suppressor Nature 2009;460:529-33.
genes (p16INK4A, p14ARF and APC) in adenocarcinomas 73. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X,
of the upper gastrointestinal tract. Int J Cancer Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y,
2004;111:224-8. Ren Z, Zen K, Zhang J, Zhang CY. Role of miR-143
69. Smith CM, Watson DI, Michael MZ, Hussey DJ. MicroRNAs, targeting KRAS in colorectal tumorigenesis. Oncogene
development of Barrett’s esophagus, and progression 2009;28:1385-92.
to esophageal adenocarcinoma. World J Gastroenterol 74. Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B,
2010;16:531-7. Streppel M, Canto M, Wang JS, Maitra A, Willis J,
70. Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Markowitz SD, Barnholtz-Sloan J, Adams MD, Chak A,
Michael MZ, South Australian Oesophageal Research G. Guda K. The microRNAs, MiR-31 and MiR-375, as candidate
MicroRNA profi ling of Barrett’s oesophagus and oesophageal markers in Barrett’s esophageal carcinogenesis. Genes
adenocarcinoma. Br J Surg 2010;97:853-61. Chromosomes Cancer 2012;51:473-9.

Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦ 129